Q4 2019 13F Holders as of 12/31/2019
-
Type / Class
-
Equity / ISHARES BIOTECH
-
Number of holders
-
697
-
Total shares
-
53.1M
-
Shares change
-
-363K
-
Total reported value, excl. options
-
$6.4B
-
Value change
-
-$7.82M
-
Put/Call ratio
-
1.76
-
Number of buys
-
245
-
Number of sells
-
-270
-
Price
-
$120.51
Significant Holders of ISHARES TR - ISHARES BIOTECH (IBB) as of Q4 2019
731 filings reported holding IBB - ISHARES TR - ISHARES BIOTECH as of Q4 2019.
ISHARES TR - ISHARES BIOTECH (IBB) has 697 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 53.1M shares
.
Largest 10 shareholders include BANK OF AMERICA CORP /DE/ (15M shares), MORGAN STANLEY (5.27M shares), CITIGROUP INC (5.22M shares), GOLDMAN SACHS GROUP INC (4.47M shares), BARCLAYS PLC (3.12M shares), UBS Group AG (2.1M shares), HEALTHCARE OF ONTARIO PENSION PLAN TRUST FUND (1.98M shares), BNP PARIBAS ARBITRAGE, SA (650K shares), TWO SIGMA INVESTMENTS, LP (641K shares), and ROYAL BANK OF CANADA (630K shares).
This table shows the top 697 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.